Graziella Filippini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.

Journal: The Cochrane database of systematic reviews

Published: April 15, 2026

Recommendations for essential medicines for multiple sclerosis in low-resource settings.

Recommendations for essential medicines for multiple sclerosis in low-resource settings.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 01, 2025

Rituximab for people with multiple sclerosis.

Rituximab for people with multiple sclerosis.

Journal: The Cochrane database of systematic reviews

Published: March 11, 2025

Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.

Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.

Journal: Multiple sclerosis and related disorders

Published: February 25, 2025

Azathioprine for people with multiple sclerosis.

Azathioprine for people with multiple sclerosis.

Journal: The Cochrane database of systematic reviews

Published: December 09, 2024

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

Journal: The Cochrane database of systematic reviews

Published: September 10, 2024

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Journal: The Cochrane database of systematic reviews

Published: January 04, 2024

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

Journal: The Cochrane database of systematic reviews

Published: November 30, 2023

Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study.

Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study.

Journal: Frontiers in psychiatry

Published: September 21, 2022

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Journal: The Cochrane database of systematic reviews

Published: May 05, 2022

Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.

Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.

Journal: Multiple sclerosis and related disorders

Published: November 16, 2021

Rituximab for people with multiple sclerosis.

Rituximab for people with multiple sclerosis.

Journal: The Cochrane database of systematic reviews

Published: November 08, 2021

Showing 1-12 of 64

Last Updated: 09/26/2026